Scholarlink

Background <p>The increasing prevalence of liver disease and diabetes mellitus in the global population highlights the importance of a complete and integrated understanding of their intricate, reciprocal relationship. The metabolic and clinical association between type 1 and type 2 diabetes mellitus and liver diseases such as cirrhosis, hepatitis, hepatocellular carcinoma (HCC), and metabolic dysfunction-associated steatotic liver disease (MASLD) is comprehensively reviewed</p> Methods <p>This review encompasses recent clinical, epidemiological, and molecular evidence addressing shared pathophysiologic mechanisms and emerging diagnostic and therapeutic approaches related to diabetes-liver disease interactions.</p> Results <p>The evidence points to similar mechanisms like oxidative stress, insulin resistance, chronic inflammation, mitochondrial dysfunction, lipotoxicity, and activation of hepatic stellate cells. There are some conditions like hepatitis C infection and metabolic disorders that make insulin resistance and blood glucose levels worsen. Moreover, it hastens liver fibrosis and affects anti-viral drug efficacy. The available treatments include medication and lifestyle changes combined with molecular-based liver treatments and liver fibrosis and other AI-based diagnostic tools. There are some limitations to the available knowledge and science. For example, there is no vaccine to prevent HCV infection and liver fibrosis. There are also some social barriers like stigma that come with liver fibrosis.</p> Conclusion <p>To reduce complications in individuals affected by diabetes and liver disorders, this article emphasizes the value of initiating early metabolic therapy, adopting integrative diagnostic methods, and pursuing personalized, multidisciplinary care.</p> <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The bidirectional relationship between diabetes mellitus and liver disease: Mechanisms, clinical implications, and management strategies

  • 期刊论文

  • 发表日期：

    2026年2月16日

查看全文
  • Manshi,
  • Debabrata Dash,
  • Raj Kumar Koiri

摘要

Background

The increasing prevalence of liver disease and diabetes mellitus in the global population highlights the importance of a complete and integrated understanding of their intricate, reciprocal relationship. The metabolic and clinical association between type 1 and type 2 diabetes mellitus and liver diseases such as cirrhosis, hepatitis, hepatocellular carcinoma (HCC), and metabolic dysfunction-associated steatotic liver disease (MASLD) is comprehensively reviewed

Methods

This review encompasses recent clinical, epidemiological, and molecular evidence addressing shared pathophysiologic mechanisms and emerging diagnostic and therapeutic approaches related to diabetes-liver disease interactions.

Results

The evidence points to similar mechanisms like oxidative stress, insulin resistance, chronic inflammation, mitochondrial dysfunction, lipotoxicity, and activation of hepatic stellate cells. There are some conditions like hepatitis C infection and metabolic disorders that make insulin resistance and blood glucose levels worsen. Moreover, it hastens liver fibrosis and affects anti-viral drug efficacy. The available treatments include medication and lifestyle changes combined with molecular-based liver treatments and liver fibrosis and other AI-based diagnostic tools. There are some limitations to the available knowledge and science. For example, there is no vaccine to prevent HCV infection and liver fibrosis. There are also some social barriers like stigma that come with liver fibrosis.

Conclusion

To reduce complications in individuals affected by diabetes and liver disorders, this article emphasizes the value of initiating early metabolic therapy, adopting integrative diagnostic methods, and pursuing personalized, multidisciplinary care.